BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28265553)

  • 1. Overview of the Use of Murine Models in Leukemia and Lymphoma Research.
    Kohnken R; Porcu P; Mishra A
    Front Oncol; 2017; 7():22. PubMed ID: 28265553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
    Vecchio E; Fiume G; Mignogna C; Iaccino E; Mimmi S; Maisano D; Trapasso F; Quinto I
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling haematopoietic malignancies in the mouse and therapeutical implications.
    Bernardi R; Grisendi S; Pandolfi PP
    Oncogene; 2002 May; 21(21):3445-58. PubMed ID: 12032781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The classification of lymphomas and leukemias.
    Ottensmeier C
    Chem Biol Interact; 2001 Jun; 135-136():653-64. PubMed ID: 11397419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt Signaling in Hematological Malignancies.
    Grainger S; Traver D; Willert K
    Prog Mol Biol Transl Sci; 2018 Jan; 153():321-341. PubMed ID: 29389522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hematopoietic cell lines and their importance in studies of leukemia and lymphoma etiopathogenesis].
    Stöckbauer P
    Cas Lek Cesk; 2002 Sep; 141 Suppl():13-7. PubMed ID: 12428416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic methods in diagnosis and treatment.
    Ward P; Kinniburgh A
    Methods Mol Med; 2001; 55():83-116. PubMed ID: 21312105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic aspects of lymphoma and leukemias.
    McCoyd M; Gruener G; Foy P
    Handb Clin Neurol; 2014; 120():1027-43. PubMed ID: 24365369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of oncogenesis and cytogenetics in leukemia and lymphoma.
    Pearson M; Rowley JD
    Annu Rev Med; 1985; 36():471-83. PubMed ID: 3888062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and classification of hematologic malignancies on the basis of genetics.
    Taylor J; Xiao W; Abdel-Wahab O
    Blood; 2017 Jul; 130(4):410-423. PubMed ID: 28600336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.
    Pattengale PK; Taylor CR
    Am J Pathol; 1983 Nov; 113(2):237-65. PubMed ID: 6605691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hematologic malignancies. Leukemia, lymphoma, and myeloma.
    Freireich EJ; Keating M; Cabanillas F; Barlogie B
    Cancer; 1984 Dec; 54(11 Suppl):2741-50. PubMed ID: 6208991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
    Huber H; Gattringer C; Thaler J; Peschel C
    Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
    Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Localization and Invasion of Tumor Cells in Mouse Models of Human and Murine Leukemias.
    Mashima K; Azuma M; Fujiwara K; Inagaki T; Oh I; Ikeda T; Umino K; Nakano H; Morita K; Sato K; Minakata D; Yamasaki R; Ashizawa M; Yamamoto C; Fujiwara SI; Hatano K; Ohmine K; Muroi K; Ohno N; Kanda Y
    Acta Histochem Cytochem; 2020 Jun; 53(3):43-53. PubMed ID: 32624629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine models of acute leukemia: important tools in current pediatric leukemia research.
    Jacoby E; Chien CD; Fry TJ
    Front Oncol; 2014; 4():95. PubMed ID: 24847444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
    Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
    J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971.
    Skipper HE; Schabel FM; Trader MW; Laster WR; Simpson-Herren L; Lloyd HH
    Cancer Chemother Rep; 1972 Jun; 56(3):273-87, 289-314. PubMed ID: 19051488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications.
    Dunphy CH
    Arch Pathol Lab Med; 2006 Apr; 130(4):483-520. PubMed ID: 16594743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling Acute Lymphoblastic Leukemia-One Fish at a Time.
    Sinha AA; Park G; Frazer JK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.